Psychobiological theories of smoking and smoking motivation

European Psychologist

Volumn 10, Issue 1, 2005, Pages 1-24

  Lujic, Claudia ^a   Reuter, Martin ^a   Netter, Petra ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Dopamine; Neurotransmitters; Nicotine dependence; Serotonin; Smoking motivation; Theories of smoking

Indexed keywords

EID: 20444472306     PISSN: 10169040     EISSN: None     Source Type: Journal    
DOI: 10.1027/1016-9040.10.1.1     Document Type: Article

References (196)

1. Acquas, E., & Di Chiara, G. (1994). Dl receptor blockade stereospecifically impairs the acquisition of drug-conditioned place-preference and place-aversion. Behavioral Pharmacology, 5, 555-569.
2. Acquas, E., Carboni, E., Leone, P., & Di Chiara, G. (1989). SCH 23390 blocks drug-conditioned place-preference and place-aversion: Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology, 99, 151-155.
3. Aitken, P.P., & Eadie, D.R. (1990). Reinforcing effects of cigarette advertising on under-age smoking. British Journal of Addiction, 85, 399-412. Amsterdam: Harwood.
4. Anokhin, A.P., Todorov, A.A., Madden, P.A., Grant, J.D., & Heath, A.C. (1999). Brain event-related potentials, dopamine D2 receptor gene polymorphism, and smoking. Genetic Epidemiology, 17(Suppl. 1), S37-S42.
5. Arai, Y., Hosokawa, T., Fukao, A., Izumi, Y., & Hisamichi, S. (1997). Smoking behavior and personality: A population-based study in Japan. Addiction, 92, 1023-1033.
6. Ashton, H., & Golding, J.F. (1989). Smoking: Motivation and models. In T. Ney & A. Gale (Eds.), Smoking and human behavior (pp. 21-56). London: Bath Press.
7. Balfour, D.J.K. (1984). The effects of nicotine on brain neurotransmitter systems. In D.J.K. Balfour (Ed.), Nicotine and the tobacco smoking habit. Oxford: Pergamon Press.
8. Balfour, D.J.K., Wright, A.E., Benwell, M.E.M., & Birrell, C.E. (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioral Brain Research, 113, 73-83.
9. Bassareo, V., & Di Chiara, G. (1997). Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. Journal of Neuroscience, 17, 851-861.
10. Bättig, K. (1998). Nicotinic and nonnicotinic aspects of smoking: Motivation and behavioral effects. In J. Snel & M.M. Lorist (Eds.), Nicotine, caffeine, and social drinking: Behavior and brain function (pp. 21-81). Amsterdam: Harwood.
11. Becona, E., Vazquez, EL., Fuentes, M.J., & Lorenzo, M.d.C. (1999). Anxiety, affect, depression, and cigarette consumption. Personality and Individual Differences, 26, 113-119.
12. Beninger, R.J. (1983). The role of dopamine in locomotor activity and learning. Brain Research Reviews, 6, 173-196.
13. Benowitz, N.L., Porchet, H., & Jacob, P., III. (1990). Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In S. Wonnacott, M.A.H. Russell, & I.P. Stolerman (Eds.), Nicotine psychopharmacology: Molecular, cellular, and behavioral aspects (pp. 112-157).
14. Benwell, M.E., & Balfour D.J. (1982). The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain. European Journal of Pharmacology, 84, 71-77.
15. Benwell, M.E.M., Balfour, D.J.K., & Anderson, J.M. (1990). Smoking-associated changes in the serotonergic systems of discrete regions of human brain. Psychopharmacology, 102, 68-72.
16. Berridge, K.C., & Robinson, T.E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28, 309-369.
17. Best, J.A., & Hakstian, A.R. (1978). A situation-specific model for smoking behavior. Addictive Behaviors, 3, 79-92.
18. Bickel, W.K., Odum, A.L., & Madden, G.J. (1999). Impulsivity and cigarette smoking: Delay of discounting in current, never, and exsmokers. Psychopharmacology, 146, 447-454.
19. Blum, K., Noble, E.P., Sheridan, P.J., Montgomery, A., Ritchie, T., Jagadeeswaran, P., Nogami, H., Briggs, A.H., & Cohn, J.B. (1990). Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association, 263, 2055-2060.
20. Bozarth, M.A. (1991). The mesolimbic dopamine system as a model reward system. In P. Willner & J. Scheel-Kruger (Eds.), The mesolimbic dopamine system: From motivation to action (pp. 301-330). New York: Wiley.
21. Bozarth, M.A., & Pudiak, C.M. (1996). Intravenous nicotine self-administration in laboratory animals: Chasing the enigma. Social and Neuroscience Abstracts, 22, 163.
22. Brauer, L.H., Behm, F.M., Lane, J.D., Westman, E.G., Perkins, C., & Rose, J.E. (2001). Individual differences in smoking reward from denicotinized cigarettes. Nicotine and Tobacco Research, 3, 101-109.
23. Brauer, L.H., Behm, F.M., Westman, E.C., Patel, P., & Rose, J.E. (1999). Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology, 143, 339-346.
24. Broderick, P.A., & Phelix C.F. (1997). Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior. Neuroscience and Biobehavioral Reviews, 21, 227-260.
25. Byrne, D.G., Byrne, A.E., & Reinhart, M.I. (1995). Personality, stress, and the decision to commence cigarette smoking in adolescence. Journal of Psychosomatic Research, 39, 53-62.
26. Canals, J., Blade, J., & Domenech, E. (1997b). Smoking and personality predictors in young Spanish people. Personality and Individual Differences, 23, 905-908.
27. Canals, J., Colomina, M.T., Domingo, J.L., & Domenech, E. (1997a). Influence of smoking and drinking habits on salivary cortisol levels. Personality and Individual Differences, 23, 593-599.
28. Carton, S., Jouvent, R., & Widlöcher, D. (1994). Sensation seeking, nicotine dependence, and smoking motivation in female and male smokers. Addictive Behaviors, 19, 219-227.
29. Cheeta, S., Irvine, E.E., Kenny, P.J., & File, S.E. (2001). The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology, 155, 78-85.
30. Coan, R.W. (1973). Personality variables associated with cigarette smoking. Journal of Personality and Social Psychology, 26, 86-104.
31. Comings, D.E., Bradshaw-Robinson, S., Burchette, R., Chiu, C., Muhleman, D. (1996). The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6, 73-79.
32. Cook, M.R., Gerkovich, M.M., Huffman, S.J., McClernon, F.J., Cohen, H.D., Oakleaf, K.L., & O'Connell, K.A. (1995). Smoking and EEG power spectra: Effects of differences in arousal seeking. International Journal of Psychophysiology, 19, 247-256.
33. Corrigall, W.A. (1991). Understanding brain mechanisms in nicotine reinforcement. British Journal of Addiction, 86, 507-510.
34. Corrigall, W.A., & Coen, K.M. (1989). Nicotine maintains robust self-administration in rats on a limited access schedule. Psychopharmacology, 99, 473-478.
35. Corrigall, W.A., Coen, K.M., & Adamson, K.L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653, 278-284.
36. Dani, J.A. (2001). Overview of nicotinic receptors and their roles in the central nervous system. Biological Psychiatry, 49, 166-174.
37. Dani, J.A.,& Heinemann, S. (1996). Molecular and cellular aspects of nicotine abuse. Neuron, 16, 905-908.
38. David, S.P., Johnstone, E., Griffiths, S.E., Murphy, M., Yudkin, P., Mant, D., & Walton, R. (2002). No association between func tional catechol O-methyl transferase 1947AG polymorphism and smoking initiation, persistent smoking, or smoking cessation. Pharmacogenetics, 12, 265-268.
39. Di Chiara, G. (1998). A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. Journal of Psychopharmacology, 12(1), 54-67.
40. Di Chiara, G. (2000). Role of dopamine in the behavioral actions of nicotine related to addiction. European Journal of Pharmacology, 393, 295-314.
41. Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavioral Brain Research, 137, 75-114.
42. Di Chiara, G., & Carboni E. (2001). Natural history of nicotine addiction: A neurobiological perspective. Polish Journal of Pharmacology, 53, 74.
43. Dubovsky, S.L., & Thomas, M. (1995). Beyond specificity: Effects of serotonin and serotonergic treatments on psychobiological dysfunction. Journal of Psychosomatic Research, 39, 429-444.
44. Duggirala, R., Almasy, L., & Blangero, J. (1999). Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genetic Epidemiology, 17(Suppl. 1), S139-S144.
45. Enoch, M.A. (2003). Pharmacogenomics of alcohol response and addiction. American Journal of Pharmacogenomics, 3, 217-32.
46. Ernst, M., Heishman, S.J., Spurgeon, L., & London, E.D. (2001). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology, 25, 313-319.
47. Eysenck, H.J. (1980). The cause and effects of smoking. London: Maurice Temple Smith.
48. Eysenck, H.J. (1991). Smoking, personality, and stress: Psychosocial factors in the prevention of cancer and coronary heart disease. New York: Springer.
49. Feldman, R.S., Meyer, J.S., & Quenzer, L.F. (1997). Principles of neuropsychopharmacology. Sunderland, MA: Sinauer Associates, Inc..
50. Foltin, R.W., & Haney, M. (2000). Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacology, 149, 24-33.
51. Foulds, J., McSorley, K., Sneddon, J., Feyerabend, C., Jarvis, M.J., & Russell, M.A. (1994). Effect of subcutaneous nicotine injections on EEG alpha frequency in nonsmokers: A placebocontrolled study. Psychopharmacology, 115, 163-166.
52. Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Wolf, A.P., Warner, D., Cilento, R., & Zezulkova, I. (1998). Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase B (MAO B) inhibition. Journal of Addictive Diseases, 17, 23-34.
53. Frith, C.D. (1971). Smoking behavior and its relation to the smoker's immediate experience. British Journal of Social and Clinical Psychology, 10, 73-78.
54. Gamberino, W.C., & Gold, M.S. (1999). Neurobiology of tobacco smoking and other addictive disorders. Addictive Disorders, 22, 301-312.
55. Gilbert, D.G. (1995). Smoking: Individual differences, psychopathology, and emotion. Philadelphia: Taylor and Francis.
56. Gilbert, D.G., & Gilbert, B.O. (1998). Nicotine and the situation by trait adaptive response (star) model: Emotional states and information processing. In J. Snel & M.M. Lorist (Eds.), Nic otine, caffeine, and social drinking: Behavior and brain function (pp. 131-149). Amsterdam: Harwood.
57. Gilbert, D.G., Meliska, C.J., & Plath, L.C. (1997). Noise stress does not modulate effects of smoking /nicotine on β-endorphin, Cortisol, ACTH, glucose, and mood. Psychopharmacology, 130, 197-202.
58. Gilbert, D.G., Sharpe, J.P., Ramanaiah, N.V., Detwiler, F.R.J., & Anderson, A.E. (2000). Development of a situation × trait adaptive response (star) model-based smoking motivation questionnaire. Personality and Individual Differences, 29, 65-84.
59. Gilbert, G.G., & Welser, R. (1989). Emotion, anxiety, and smoking. In T. Ney & A. Gale (Eds.), Smoking and human behavior (pp. 171-196). London: Bath Press.
60. Gorelick, D.A., Rose, J., & Jarvik, M.E. (1989). Effect of nalox-one on cigarette smoking. Journal of Substance Abuse, 1, 153-159.
61. Helgason, A.R., Fredrikson, M., Dyba, T., & Steineck, G. (1995). Notes and shorter communications. Introverts give up smoking more often than extraverts. Personality and Individual Differences, 18(4), 559-560.
62. Henningfield, J.E., Miyasato, K., & Jasinski, D.R. (1983). Cigarette smokers self-administer intravenous nicotine. Pharmacology, Biochemistry, and Behavior, 19, 887-890.
63. Houlihan, M., Pritchard, W., & Robinson, J. (2001). EEG effects of smoking: Is there tachyphylaxis? Neuropsychobiology, 44, 54-58.
64. Ikard, F.F., Green, D.E., & Horn, D. (1969). A scale to differentiate between types of smoking as related to management of affect International Journal of the Addictions 4, 649-659.
65. Ito, H., Hamajima, N., Matsuo, K., Okuma, K., Sato, S., Ueda, R., & Tajima, K. (2003). Monoamine oxidase polymorphisms and smoking behavior in Japanese. Pharmacogenetics, 13, 73-79.
66. Janke, W., Debus, G., & Longo, N. (1979). Differential psychopharmacology of tranquilizing and sedating drugs. In T.A. Ban, FA. Freyhan, P. Pichot, & W. Poeldinger (Eds.), Modern problems of pharmacopsychiatry (Vol. 14). Basel: Karger.
67. Jorm, A., Henderson, A., Jacomb, P., Christensen, H., Korten, A., Rodgers, B. et al. (2000). Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey. American Journal of Medical Genetics, 96, 331-334.
68. Joseph, S., Manafi, E., Iakovaki, A.M., & Cooper, R. (2003). Personality, smoking motivation, and self-efficacy to quit. Personality and Individual Differences, 34, 749-758.
69. Kalivas, P.W., & Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research Reviews, 16, 223-244.
70. Kendler, K.S., Neale, M.C., Sullivan, P., Corey, L.A., Gardner, C.O., & Prescott, C.A. (1999). A population-based twin study in women of smoking initiation and nicotine dependence. Psychological Medicine, 29, 299-308.
71. Kirch, D.G., Gerhardt, G.A., Shelton, R.C., Freedman, R., & Wyatt, R.J. (1987). Effects of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clinical Neuropharmacology, 10, 376-383.
72. Kirschbaum, C., Pirke, K.M., & Hellhammer, D. (1993) The " Trier Social Stress Test" - A tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology, 25, 76-81.
73. Kleinke, C.L., Staneski, R.A., & Meeker, F.B. (1983). Attributions for smoking behavior: Comparing smokers with nonsmokers and predicting smokers' cigarette consumption. Journal of Research in Personality, 17, 242-255.
74. Knott, V.J., Harr, A., & Lusk-Mikkelsen, S. (1998). Functional utility of nicotine: Arousal, mood, and performance. In J. Snel & M.M. Lorist (Eds.), Nicotine, caffeine, and social drinking: Behavior and brain function (pp. 115-130). Amsterdam: Harwood.
75. Koob, G.F., & Le Moal M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.
76. Koob, G.F., & Le Moal, M. (1997). Drug abuse: Hedonic homeostatic dysregulation. Science, 278, 52-58.
77. Krogh, D. (1993). Rauchen: Sucht und Leidenschaft [Smoking: Addiction and passion]. Heidelberg: Spektrum.
78. Le Houezec, J. (1998). Pharmacokinetics and pharmacodynamics of nicotine. In J. Snel & M.M. Lorist (Eds.). Nicotine, caffeine and social drinking: Behavior and brain function (pp. 3-19). Amsterdam: Harwood.
79. Lerman, C., Audrain, J., Main, D., Boyd, N.R., Caporaso, N.E., Bowman, E.D., Lockshin, B., & Shields, P.G. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology, 18(1), 14-20.
80. Lerman, C, Caporaso, N.E., Audrain, J., Main, D., Boyd, N.R., & Shields, P.G. (2000). Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry, 5, 189-192.
81. Lerman, C., Caporaso, N.E., Bush, A., Zheng, Y.L., Audrain, J., Main, D., & Shields, P.G. (2001). Tryptophan hydroxylase gene variant and smoking behavior. American Journal of Medical Genetics, 105, 518-520.
82. Levin, E.D., Conners, C.K., Silva, D., Hinton, S.C., Meek, W.H., March, J., & Rose, J.E. (1998). Transdermal nicotine effects on attention. Psychopharmacology, 140, 135-141.
83. Levin, E.D., Rose, J.E., Behm, F., & Caskey, N.H. (1992). The effects of smoking-related sensory cues on psychological stress. Pharmacology, Biochemistry, and Behavior, 39, 265-268.
84. Li, M.D. (2003). The genetics of smoking related behavior: Abrief review. American Journal of Medical Sciences, 326, 168-173.
85. Maes, H., Woodward, C.E., Murrelle, L., Meyer, J.M., Silberg, J.L., Hewitt, J.K., Rutter, M., Simonoff, E., Pickles, A., Carbonneau, R., Neale, M.C., & Eaves, L.J. (1999). Tobacco, alcohol, and drug use in eight-to sixteen-year-old twins: The Virginia twin study of adolescent behavioral development. Journal of Studies on Alcohol, 293-305.
86. Martin-Soelch, C., Leenders, K.L., Chevalley, A.-F., Missimer, J., Künig, G., Magyar, S., Mino, A., & Schultz, W. (2001). Reward mechanisms in the brain and their role in dependence: Evidence from neurophysiological and neuroimaging studies. Brain Research Reviews, 36, 139-149.
87. McKennell, A.C. (1970). Smoking motivation factors. British Journal of Social and Clinical Psychology, 9, 8-22.
88. McKinney, E.F., Walton, R.T., Yudkin, P., Fuller, A., Haldar, N.A., Mant, D. et al. (2000). Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics, 10, 483-491.
89. Meany, M.J., Brake, W., & Gratton, A. (2002). Environmental regulation of the development of mesolimbic dopamine systems: A neurobiological mechanism for vulnerability to drug abuse. Psychoneuroendocrinology, 27, 127-138.
90. Meliska, C.J., & Gilbert, D.G. (1991). Hormonal and subjective effects of smoking the first five cigarettes of the day: A comparison in males and females. Pharmacology, Biochemistry, and Behavior, 40, 229-235.
91. Mitchell, S.H. (1999). Measures of impulsivity in cigarette smokers and nonsmokers. Psychopharmacology, 146, 455-464.
92. Montgomery, A.M.J., & Grottick, A.J. (1999). Neurotransmitter system interactions revealed by drug-induced changes in motivated behavior. Pharmacology, Biochemistry, and Behavior, 62, 643-657.
93. Mucha, R.F., Geier, A., & Pauli, P. (1999). Modulation of craving by cues having differential overlap with pharmacological effect: Evidence for cue approach in smokers and social drinkers. Psychopharmacology, 147, 306-313.
94. Nestler, E.J., & Aghajanian G.K. (1997). Molecular and cellular basis of addiction. Science, 278, 58-63.
95. Netter, P., Hennig, J., Huwe, S., & Olbrich, R. (1998). Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking. Psychopharmacology, 135, 52-62.
96. Netter, P., Müller, M.J., Neumann, A., & Kamradik, B. (1994). The influence of nicotine on performance, mood, and physiological parameters as related to smoking habit, gender, and suggestibility. Clinical Investigator, 72, 512-518.
97. Netter, P., Toll, C., Lujic, C., Reuter, M., & Hennig, J. (2002). Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems. Behavioral Pharmacology, 13, 441-449.
98. Newcomb, M.D., McCarthy, W.J., & Bentler, P.M. (1989). Cigarette smoking, academic lifestyle, and social impact efficacy: An eight-year study from early adolescence to young adulthood. Journal of Applied Social Psychology, 19, 251-281.
99. Nil, R., Woodson, Ph., & Bättig, K. (1982). Der Raucher, sein Rauchverhalten und seine Rauchmotivation [The smoker, his smoking behavior, and his smoking motivation] Schweizerische Zeitschrift für Psychologie, 41, 217-229.
100. Noble, E.P. (2000). Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene. European Psychiatry, 15, 79-89.
101. Noble, E.P., Stjeor, S.T., Ritchie, T., Syndulko, K., Stjeor, S.C., & Fitch, R.J.(1994). D2 dopamine receptor gene and cigarette smoking: A reward gene? Medical Hypotheses, 42, 257-260.
102. O'Neill, S.T., & Parrott, A.C. (1992). Stress and arousal in sedative and stimulant cigarette smokers. Psychopharmacology, 107, 442-446.
103. Olausson, P., Åkesson, P., Engel, J.A., & Söderpalm B. (2001). Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. European Journal of Pharmacology, 420, 45-54.
104. Olausson, P., Åkesson, P., Petersson, A., Engel, J.A., & Söderpalm B. (2001). Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin depleted rat. Psychopharmacology, 155, 348-361.
105. Papakyriazi, E., & Joseph, S. (1998). Individual differences in personality among smokers and their association with smoking motivation, social skills deficit, and self-efficacy to quit Personality and Individual Differences, 25, 621-626.
106. Parrott, A.C., & Craig, D. (1995). Psychological functions served by nicotine chewing gum. Addictive Behaviors, 20, 271-278.
107. Parrott, A.C. (1994). Individual differences in stress and arousal during cigarette smoking. Psychopharmacology, 115, 389-396.
108. Parrott, A.C. (1995). Stress modulation over the day in cigarette smokers. Addiction, 90, 233-244.
109. Parrott, A.C. (1998). Nesbitt's paradox resolved? Stress and arousal modulation during cigarette smoking. Addiction, 93, 27-39.
110. Parrott, A.C., & Joyce, C. (1993). Stress and arousal rhythms in cigarette smokers, deprived smokers, and nonsmokers. Human Psychopharmacology, 8, 21-28.
111. Pauli, J.R., Grun, E.U., & Collins, A.C. (1992). Glucocorticoid regulation of sensitivity to nicotine. In P.M. Lippiello, A.C. Collins, & J.A. Gray (Eds.), The biology of nicotine: Current research issues (pp. 121-137). New York: Raven.
112. Pauly, J.R., Grun, E.U., & Collins, A.C. (1992). Tolerance to nicotine following chronic treatment by injections: A potential role for corticosterone. Psychopharmacology,108, 33-39.
113. Pettit, H.O., & Justice, J.B. (1989). Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacology, Biochemistry and Behavior, 34, 899-904.
114. Pettit, H.O., & Justice, J.B. (1991). Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Research, 539, 94-102.
115. Piasecki, T.M., Kenford, S.L., Smith, S.S., Fiore, M.C., & Baker, T.B. (1997). Listening to nicotine: Negative affect and the smoking withdrawal conundrum. Psychological Science, 8, 184-189.
116. Piazza, P.V., & Le Moal, M. (1996). Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annual Reviews of Pharmacology and Toxicology, 36, 359-378.
117. Picciotto, M.R. (1998). Common aspects of the action of nicotine and other drugs of abuse. Drug and Alcohol Dependence, 51, 165-172.
118. Pickworth, W.B., & Fant, R.V. (1998). Endocrine effects of nicotine administration, tobacco, and other drug withdrawal in humans. Psychoneuroendocrinology, 23, 131-141.
119. Pierce, R.C., & Kalivas, P.W. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research Reviews, 25, 192-216.
120. Pohjalainen, T., Rinne, J.O., Nagren, K., Lehikoinen, P., Anttila, K., & Syvälahti, E.K.G. (1998). The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molecular Psychiatry, 3, 256-260.
121. Pomerleau, O.F. (1998). Endogenous opioids and smoking: A review of progress and problems. Psychoneuroendocrinology, 23, 115-130.
122. Pomerleau, O.F., & Pomerleau C.S. (1987). A biobehavioral view of substance abuse and addiction. Journal of Drug Issues, 87, 111-131.
123. Pomerleau, O.F., & Pomerleau C.S. (1989). A biobehavioral perspective on smoking. In T. Ney & A. Gale (Eds.), Smoking and human behavior (pp. 69-90). London: Bath Press.
124. Pomerleau, O.F., & Pomerleau C.S. (1991). Research on stress and smoking: Progress and problems. British Journal of Addiction, 86, 599-603.
125. Pritchard, W.S. (1991). The link between smoking and P: A serotonergic hypothesis. Personality and Individual Differences, 12, 1187-1204.
126. Pritchard, W.S., & Robinson, J.H. (1998). Effects of nicotine on human performance. In J. Snel and M.M. Lorist (Eds.), Nico tine, caffeine, and social drinking: Behavior and brain function (pp. 21-81). Amsterdam: Harwood.
127. Pritchard, W.S., & Kay, D.L. (1993). Personality and smoking motivation of U.S. smokers as measured by the state-trait personality inventory, the Eysenck personality questionnaire, and Spielberger's smoking motivation questionnaire. Personality and Individual Differences, 14, 629-637.
128. Pulvirenti, L., & Koob, G.K. (1994). Dopamine receptor agonists, partial agonists, and psychostimulant addiction Trends in Pharmacological Science 15, 374-379.
129. Rasmussen, D.D. (1998). Effects of chronic nicotine treatment and withdrawal on hypothalamic propiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology, 23, 245-259.
130. Reuter, M., & Hennig, J. (2003). Cortisol as an indicator of dopaminergic effects on nicotine craving. Human Psychopharmacology: Clinical and Experimental, 18, 437-446.
131. Reuter, M. (2002). The impact of cortisol for emotions in stress and nonstress conditions: A pharmacopsychological approach. Neuropsychobiology, 46, 41-48.
132. Ripa, C.P.L., Hansen, H.S., Mortensen, E.L., Sanders, S.A., & Reinisch, J.M. (2001). A Danish version of the sensation seeking scale and its relation to a broad spectrum of behavioral and psychological characteristics. Personality and Individual Differences, 30, 1371-1386.
133. Robinson, T.E., & Becker, J.B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Research, 396, 157-198.
134. Robinson, T.E., & Berridge, K.C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
135. Robinson, T.E., & Berridge, K.C. (2000). The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction 95, 91-117.
136. Robinson, T.E., & Berridge, K.C. (2001). Mechanisms of action of addictive stimuli. Incentive-sensitization and addiction. Addiction, 96, 103-114.
137. Robinson, T.E., & Berridge, K.C. (2003). Addiction. Annual Reviews of Psychology, 54, 25-53.
138. Rose, J.E. (1985). Sensory blockade of smoking satisfaction. Pharmacology, Biochemistry, and Behavior, 23, 289-293.
139. Rose, J.E., Behm, F.M., Westman, E.C., & Johnson, M. (2000). Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry, and Behavior, 67, 71-81.
140. Rose, J.E., Behm, F.M., Westman, E.C., Mathew, R.J., London, E.D., Hawk, T.C., Turkington, T.G., & Coleman, R.E. (2003). PET studies of the influence of nicotine on neural systems in cigarette smokers. American Journal of Psychiatry, 160, 323-333.
141. Rosecrans, J.A., & Karan, L.D. (1993). Neurobehavioral mechanisms of nicotine action: Role in the initiation and maintenance of tobacco dependence, Journal of Substance Abuse and Treatment, 10, 161-170.
142. Routtenberg, A. (1968). The two-arousal hypothesis: Reticular formation and limbic system. Psychological Reviews, 75, 51-80.
143. Russell, M.A.H. (1974). The smoking habit and its classification. The Practitioner, 212, 791-800.
144. Russell, M.A.H. (1979). Nicotine intake and its regulation. Journal of Psychosomatic Research, 24, 253-264.
145. Russell, M.A.H., Peto, J., & Patel, U.A. (1974). The classification of smoking by factorial structure of motives. Journal of the Royal Statistical Society, 137, 313-346.
146. Rusted, J.M., Mackee, A., Williams, R., & Willner, P. (1998). Deprivation state but not nicotine content of the cigarette affects responding by smokers on a progressive ratio task. Psychopharmacology, 140, 411-417.
147. Sasco, A.J., & Kleihues, P. (1999). Why can't we convince the young not to smoke. European Journal of Cancer, 35, 1933-1940.
148. Sasco, A.J., Merrill, R.M., Bernhaim-Luzon, V., Gerard, J.-P., & Freyer, G. (2003). Trends in tobacco smoking among adolescents in Lyon, France. European Journal of Cancer, 39, 496-504.
149. Scheitrum, R.R., & Akillas, E. (2002). Effects of personality style, anxiety, and depression on reported reasons for smoking. Journal of Applied Biobehavioral Research, 7, 57-64.
150. Scherer, G. (1999). Smoking behavior and compensation: A review of the literature. Psychopharmacology, 145, 1-20.
151. Schwarzer, R. (1992). Psychologie des Gesundheitsverhaltens [translation please]. Göttingen: Hogrefe.
152. Semmer, N.K., Dwyer, J., Lippert, P., Fuchs, R., Cleary, P., & Schindler, A. (1987). Adolescent smoking from a functional perspective: The Berlin-Bremen study. European Journal of Psychology of Education, 2, 387-402.
153. Shahan, T.A., Bickel, W.K., Madden, G.J., & Badger, G.J. (1999). Comparing the reinforcing efficacy of nicotine-containing and denicotinized cigarettes: A behavioral economic analysis. Psychopharmacology, 147, 210-216.
154. Shields, P.G., Lerman, C., Audrain, J., Bowman, E.D., Main, D., Boyd, N.R., Caporaso, N.B. (1998). Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiology, Biomarkers, and Prevention, 7, 453-458.
155. Shiffman, S. (1986). A cluster-analytic classification of smoking relapse episodes. Addictive Behaviors, 11, 295-307.
156. Silbereisen, R.K., & Noack, P. (1986). On the constructive role of problem behavior in adolescence. Berichte der Arbeitsgruppe Tudrop Jugendforschung Nr. 72. Berlin: Technische Universität, Institut für Psychologie.
157. Simons-Morton, B., Crump, A.D., Haynie, D.L., Saylor, K.E., Eitel, P., & Yu, K. (1999). Psychosocial, school, and parent factors associated with recent smoking among early-adolescent boys and girls. Preventive Medicine, 28, 138-148.
158. Smith, K.M., Mitchell, S.N., & Joseph, M.H. (1991). Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurons in the rat brain. Journal of Neurochemistry, 57, 1750-1756.
159. Spanagel, R., & Weiss, F. (1999). The dopamine hypothesis of reward: Past and current status. Trends in Neuroscience, 22, 521-527.
160. Spielberger, C.D. (1986). Psychological determinants of smoking behavior. In R.D. Tollison (Ed.). Smoking and society: Toward a more balanced assessment (pp. 89-134). Massachusetts, Toronto: Lexington Books.
161. Spielberger, C.D., Foreyt, J.P., Goodrick, K., & Reheiser, E.C. (1995). Personality characteristics of users of smokeless tobacco compared with cigarette smokers and nonusers of tobacco products. Personality and Individual Differences, 19, 439-448.
162. Stalke, J., Hader, O., Bähr, V., Hensen, J., Scherer, G., & Oelkers, W. (1992). The role of vasopressin in the nicotine-induced Stimulation of ACTH and cortisol in men. Clinical Investigator, 70, 218-223.
163. Stanaway, R.G., & Watson, D.W. (1981). Smoking and personality: A factorial study. British Journal of Clinical Psychology, 20, 213-214.
164. Stewart, J., & Badiani, A. (1993). Tolerance and sensitization to the behavioral effects of drugs. Behavioral Pharmacology, 4, 289-312.
165. Stolerman, I.P. (1991). Behavioral pharmacology of nicotine: Multiple mechanisms. British Journal of Addiction, 86, 533-536.
166. Stolerman, I.P., & Shoaib, M. (1991). The neurobiology of tobacco addiction. Trends in Pharmacological Science 12, 467-473.
167. Sullivan, P.F., & Kendler, K.S. (1999). The genetic epidemiology of smoking. Nicotine & Tobacco Research, 1(Suppl 2), 51-57.
168. Sullivan, PR, Jiang, Y., Neale, M.C., Kendler, K.S., & Straub, R.E. (2001). Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. American Journal of Medical Genetics, 105, 479-484.
169. Sutherland, I., & Shepherd, J.P. (2001). Social dimensions of adolescent substance abuse. Addiction, 96, 445-458.
170. Swan, G.E., Carmelli, D., & Rosenman, R.H. (1988). Psychological characteristics in twins discordant for smoking behavior: A matched twin-pair analysis. Addictive Behaviors, 13(1), 51-60.
171. Takemura, Y., Akanuma, M., Kikuchi, S., & Inaba, Y (1999). Cross-sectional study on the relationship between smoking or smoking cessation and trait anxiety. Preventive Medicine, 29, 496-500.
172. Tiffany, S.T. (1990). A cognitive model of drug urges and drug use behavior: Role of automatic and nonautomatic processes. Psychological. Reviews, 97, 147-168.
173. Tomkins, S. (1966). Psychological model for smoking behavior. American Journal of Public Health, 56, 17-20.
174. Tomkins, S. (1968). A modified model of smoking behavior. In E.F. Borgatta & R.J. Evans (Eds.), Smoking, health, and behavior (pp. 165-186). Chicago, IL: Aldine.
175. Tricker, A.R. (2003). Nicotine metabolism, human drug metabolism polymorphisms, and smoking behavior. Toxicology, 183, 151-173.
176. True, W.R., Heath, A.C., Scherrer, J.F., Waterman, B., Goldberg, J., Lin, N., Eisen, S.A., Lyons, M.J., & Tsuang, M.T. (1997). Genetic and environmental contributions to smoking. Addiction, 92, 1277-1287.
177. Vandenbergh, D., Bennett, C., Grant, M., Strasser, A., O'Connor, R., Stauffer, R., Vogler, G., & Kozlowski, L. (2002). Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: Failure to replicate and finding that never-smokers may be different. Nicotine & Tobacco Research, 4, 333-340.
178. Volle, R.L., & Koelle, G.B. (1975). Ganglionic stimulating and blocking agents. In L.S. Goodman & A. Gilman (Eds.), The pharmacological basis of therapeutics (5th ed.,pp. 565-574). New York: Macmillan.
179. Warburton, D.M. (1990). Controversies in substance use research. In D.M. Warburton (Ed.), Addiction controversies (pp. 314-329). Chur: Harwood.
180. Warburton, D.M., & Wesnes, K. (1978). Individual differences in smoking and attentional performance. In R.E. Thornton (Ed.), Smoking behavior: Physiological and psychological influences (pp. 19-43). London: Churchill-Livingstone.
181. Warburton, D.M., Revell, A.D., & Thompson, D.H. (1991). Smokers of the future. British Journal of Addiction, 86, 621-625.
182. Warburton, D.M., Wesnes, K., Shergold, K., & James, M. (1986). Facilitation of learning and state dependency with nicotine. Psychopharmacology, 89, 55-59.
183. Watkins, S.S., Koob, G.F., & Markou, A. (2000). Neural mechanisms underlying nicotine addiction. Nicotine & Tobacco Research, 2, 19-37.
184. Weiss, F., Markou, A., Lorang, M.T., & Koob, G.F. (1992). Basal dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Research, 593, 314-318.
185. Wesnes, K., & Revell. A. (1984). The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology, 84, 5-11.
186. Wesnes, K., Warburton, D.M. (1978). The effects of cigarette smoking and nicotine tablets upon human attention: In R.E. Thornton (Ed.), Smoking behavior: Physiological and psychological influences (pp. 131-142). London, Edinburgh: Churchill-Livingstone.
187. West, R. (1992). Nicotine addiction: A reanalysis of the arguments. Psychopharmacology, 108, 408-410.
188. Wetter, D.W., Brandon, T.H., & Baker, T.B. (1992). The relation of affective processing measures and smoking motivation indices among college-age smokers. Advances in Behavior Research and Therapy, 14, 169-193.
189. Wetterer, A., & von Troschke, J. (1986). Smoker motivation: A review of contemporary literature. Berlin, Heidelberg: Springer-Verlag.
190. Wewers, M.E., Dhatt, R., & Tejwani, G.A. (1998). Naltrexone administration affects ad libitum smoking behavior. Psychopharmacology, 140, 185-190.
191. White, F.J., & Kalivas, P.W. (1998). Neuroadaptations involved in amphetamine and cocaine addiction. Drug and Alcohol Dependence, 51, 141-153.
192. Woodson, P.P., Bättig K., & Rosecrans J.A. (1982). Nikotinwirkungen auf visuelle evozierte EEG-Potentiale [translation?]. Medicine Sociale et Preventive, 27, 242-243.
193. Yoshida K., Hamajima, N., Kozaki, K., Saito H., Maeno, K., Sugiura, T., Ookuma, K., & Takahashi, T. (2001). Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiology Biomarkers & Prevention, 10, 403-405.
194. Zaimov, K.A., Fertcheva, A., & Vanev, P.I. (1994). Motives of smoking and inborn behavioral preprogram of the personality. The International Journal of the Addictions, 29, 957-970.
195. Zuckerman, M., & Kuhlman, D.M. (2000). Personality and risk taking: Common biosocial factors. Journal of Personality, 68, 999-1029.
196. Zuckerman, M., Ball, S., & Black, J. (1990). Influences of sensation seeking, gender, risk appraisal, and situational motivation on smoking. Addictive Behaviors, 15, 209-220.